Zimmer Hip Implant Recall
On July 24, 2008, Zimmer Holdings, the nation’s largest producer of orthopedic devices, suspended U.S. sales of an artificial hip implant component, known as the ‘Durom cup,’ due to a high failure rate. Zimmer has sold nearly 12,000 of the implants in the United States since 2006. In April 2008, Dr. Lawrence Dorr, an orthopedic surgeon in Los Angeles, California, publicly warned other orthopedists about the high number of cup failures his patients were experiencing. In a July 24, 2008 interview, Dr. Dorr told the New York Times that the Durom Cup was “a bad design.” Zimmer denies that the implants are defective but in a letter to orthopedic surgeons dated July 22, 2008, acknowledged that some patients with the Durom Cup implant may require revision surgery. Critics of the device fear that hundreds of patients may require implant replacement.
Questions and Consultations
If you or someone you love received a Zimmer Durom Cup artificial hip implant after March 16, 2006, and you would like to discuss your rights, please complete our brief evaluation form. A member of Seeger Weiss LLP’s experienced staff will call you to discuss your potential claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in New York, New Jersey, Pennsylvania and California, and its attorneys practice in courts throughout the country.
Free Case Evaluation
Legal action was recently filed against the Tropical Smoothie Café after patrons were exposed to the hepatitis A virus after drinking tropical smoothies sold by the national chain of restaurants. This initial [...]September 26, 2016 By: Seeger Weiss read more
Chevrolet’s so-called “clean diesel” models Cruze and Colorado emit higher levels of pollution than originally disclosed to the government, and more than the company claimed was emitted in its marketing [...]September 2, 2016 By: Seeger Weiss read more
For some time, Janssen Pharmaceutical’s diabetes medication Invokana has been known to trigger serious side effects, including ketoacidosis, in users. Ketoacidosis occurs when there is a presence of abnormally high ketones in [...]August 31, 2016 By: Seeger Weiss read more